Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 6 Issue: 4, June

Targeted Therapies in Non-Small Cell Lung Cancer: Proven Concepts and Unfulfilled Promises.

Volume:6   Issue: 4
Pp: 271-294
Jutta Auberger, Judith Loeffler-Ragg, Walter Wurzer and Wolfgang Hilbe
DOI: 10.2174/156800906777441780
Published on: 01 March, 2012

Regulation of Multidrug Resistance by Pro-Inflammatory Cytokines

Volume:6   Issue: 4
Pp: 295-311
Emmanuel A. Ho and Micheline Piquette-Miller
DOI: 10.2174/156800906777441753
Published on: 01 March, 2012

NOTCH Signaling as a Novel Cancer Therapeutic Target

Volume:6   Issue: 4
Pp: 313-323
L. Miele, H. Miao and B. J. Nickoloff
DOI: 10.2174/156800906777441771
Published on: 01 March, 2012

The Use of Thalidomide in Myeloma Therapy as an Effective Anticancer Drug

Volume:6   Issue: 4
Pp: 325-331
Daniel M.-Y. Sze, Ross Brown, Shihong Yang, P. J. Ho, John Gibson and Douglas Joshua
DOI: 10.2174/156800906777441762
Published on: 01 March, 2012

Targeted Therapies in Gynecologic Cancers

Volume:6   Issue: 4
Pp: 333-363
Hye S. Chon, Wei Hu and John J. Kavanagh
DOI: 10.2174/156800906777441799
Published on: 01 March, 2012